The Journal of Thoracic and Cardiovascular Surgery
Volume 134, Issue 5 , Pages 1150-1156 , November 2007

Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis

  • Bertrand Marcheix, MD, MSc

      Affiliations

    • Department of Cardiovascular Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
  • ,
  • Yoan Lamarche, MD, MSc

      Affiliations

    • Department of Cardiovascular Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
  • ,
  • Colin Berry, MD, PhD

      Affiliations

    • Department of Cardiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • Dr Berry was supported by a British Heart Foundation International Fellowship.
  • ,
  • Anita Asgar, MD

      Affiliations

    • Department of Cardiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
  • ,
  • Jean-Claude Laborde, MD

      Affiliations

    • Department of Interventional Cardiology, Clinique Pasteur, Toulouse, France
    • Drs Bonan and Laborde are consultants to CoreValve, Inc, Paris, France.
  • ,
  • Arsène Basmadjian, MD, MSc

      Affiliations

    • Department of Cardiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
  • ,
  • Anique Ducharme, MD, MSc

      Affiliations

    • Department of Anesthesiology, Montreal Heart Institute, Montreal, Quebec, Canada.
  • ,
  • André Denault, MD

      Affiliations

    • Department of Anesthesiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
  • ,
  • Raoul Bonan, MD

      Affiliations

    • Department of Cardiology, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • Drs Bonan and Laborde are consultants to CoreValve, Inc, Paris, France.
  • ,
  • Raymond Cartier, MD

      Affiliations

    • Department of Cardiovascular Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
    • Corresponding Author InformationAddress for reprints: Raymond Cartier, MD, Department of Cardiovascular Surgery, Montreal Heart Institute, 5000 Belanger Street, Montreal, Quebec H1T 1C8, Canada.

Received 9 February 2007 ,Revised 3 July 2007 ,Accepted 10 July 2007.

References 

  1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231–1243
  2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011
  3. Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35:747–756
  4. Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105–1110
  5. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?. Eur Heart J. 2005;26:2714–2720
  6. Cribier A, Saoudi N, Berland J, Savin T, Rocha P, Letac B. Percutaneous trans-luminal valvuloplasty of acquired aortic-stenosis in elderly patients—alternative to valve-replacement. Lancet. 1986;1:63–67
  7. Eltchaninoff H, Cribier A, Tron C, Anselme F, Koning R, Soyer R, et al. Balloon aortic valvuloplasty in elderly patients at high-risk for surgery, or inoperable—immediate and mid-term results. Eur Heart J. 1995;16:1079–1084
  8. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–1405
  9. Berry C, Lamarche Y, Laborde JC, Cartier R, Denault A, Basmadjian A, et al. First case of combined percutaneous aortic valve replacement and coronary artery revascularisation. EuroIntervention. 2006;2:257–261
  10. Grube E, Laborde JC, Zickmann B, Gerckens U, Felderhoff T, Sauren B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve. Catheter Cardiovasc Interv. 2005;66:465–469
  11. Lamarche Y, Berry C, Cartier R, Denault A, Basmadjian A, Laborde JC, et al. First North American implantation of the CoreValve percutaneous aortic valve. Ann Thorac Surg. 2007;83:284–287
  12. Lichtenstein S, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, et al. Transapical transcatheter aortic valve implantation in humans (Initial clinical experience). Circulation. 2006;114:591–596
  13. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842–850
  14. Boudjemline Y, Bunhoeffer D. Steps toward percutaneous aortic valve replacement. Circulation. 2002;105:775–778
  15. Laborde JC, Borenstein N, Behr L, Farah B, Fajadet J. Percutaneous implantation of an aortic valve prosthesis. Catheter Cardiovasc Interv. 2005;65:171–174
  16. Sunder-Plassmann L, Scharrer-Pamler R, Liewald F, Kapfer X, Gorich J, Orend KH. Endovascular exclusion of thoracic aortic aneurysms: mid-term results of elective treatment and in contained rupture. J Card Surg. 2003;18:367–374
  17. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698–703
  18. Webb JG, Munt B, Makkar RR, Naqvi TZ, Dang N. Percutaneous stent-mounted valve for treatment of aortic or pulmonary valve disease. Catheter Cardiovasc Interv. 2004;63:89–93
  19. Hannan E, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, et al. Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg. 2007;83:921–930
  20. Berry C, Cartier R, Bonan R. Fatal ischemic stroke related to non-permissive peripheral artery access for percutaneous aortic valve replacement. Catheter Cardiovasc Interv. 2007;69:56–63

PII: S0022-5223(07)01300-1

doi: 10.1016/j.jtcvs.2007.07.031

The Journal of Thoracic and Cardiovascular Surgery
Volume 134, Issue 5 , Pages 1150-1156 , November 2007